Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 10 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 OE $26.49 $397,350 D/D 15,000 143,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-03 4 D $93.95 $274,710 D/D (2,924) 125,518 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-15 4 D $92.50 $473,230 D/D (5,116) 120,402 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-22 4 A $0.00 $0 D/D 19,790 140,192 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-04-28 4 A $70.30 $21,232 D/D 302 140,494 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-05-15 4 D $91.50 $186,294 D/D (2,036) 138,458 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-02 4 D $90.72 $184,706 D/D (2,036) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-16 4 AS $90.00 $1,295,730 D/D (14,397) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-16 4 OE $26.49 $484,462 D/D 14,397 150,819 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-19 4 AS $90.00 $54,270 D/D (603) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-19 4 OE $37.46 $22,588 D/D 603 137,025 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-09-15 4 AS $90.50 $1,357,500 D/D (15,000) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-09-15 4 OE $26.49 $507,050 D/D 15,000 151,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-01-02 4 OE $26.49 $507,050 D/D 15,000 148,976 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-01-02 4 AS $89.23 $1,338,401 D/D (15,000) 133,976 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-02-26 4 A $0.00 $0 D/D 20,324 153,885 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-02-26 4/A A $0.00 $0 D/D 20,463 154,024 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-02 4 D $79.86 $205,719 D/D (2,576) 151,309 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-15 4 D $83.57 $406,234 D/D (4,861) 146,448 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-15 4 A $0.00 $0 D/D 16,040 162,488 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4 D $81.36 $472,864 D/D (5,812) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4/A D $81.36 $474,736 D/D (5,835) 156,653 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 OE $26.49 $337,851 D/D 10,000 163,326 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 AS $80.12 $801,200 D/D (10,000) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-30 4 A $68.78 $21,254 D/D 309 157,101 0 -
  294  Records found
  1   2   3   4   5   6   7   8   9   10  11   12      
  Page 10 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us